Figure 6From: WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cellsWNT5A induces release of exosomes that contain solube mediators. (A) Electronmicroscopic picture of isolated exosome fraction from supernatant of Mewo cells treated with 0.2 μg/ml rWNT5A for 3 h. (B) Western blot of isolated exosomes from supernatant of Mewo cell stimulated with 0.2 μg/ml rWNT5A, carrier or 0.1 ng/ml rWNT3A for 3 h. GAPDH (upper), CD63 (center) and Rab5b (lower). (C) Quantitative Exosome Elisa (ExoELISA) of isolated exosome fraction from Mewo cells transfected with pcDNA3 or CA-Cdc42. The bar graphs show the relative increase of exosomes produced in CA-Cdc42 transfected as compared to pcDNA3 transfected Mewo cells. Error bars represent SEM. n = 5. * = p <0.05 by Student’s t-test. (D) IL-6 or (E) MMP2 levels as measured by Elisa of frozen exosome fractions isolated from supernatant of Mewo cells that were treated with 0.2 μg/ml rWNT5A, carrier or 0.1 ng/ml rWNT3A for 3 h. The low protein yield in the isolated exosome fractions might explain the higher relative background level in the control as compared to IL-6 measured in supernatant. The bar graphs show average fold increase as compared to carrier (ctrl) for each treatment indicated. Error bars represent SD. n = 3. * = p <0.05, ** = p <0.01 by Student’s t-test.Back to article page